Covered recipient · General Payments record
SHAHZAD A CHOUDHRY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2022–2023
$653.88
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $580.25 | 26 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $283.85 | 12 |
| ITI, Inc. | $97.81 | 4 |
| Janssen Pharmaceuticals, Inc | $35.57 | 2 |
| Corium, Inc. | $34.14 | 1 |
| Lundbeck LLC | $30.79 | 2 |
| Teva Pharmaceuticals USA, Inc. | $30.19 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.57 | 1 |
| Almatica Pharma Inc. | $17.64 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.22 | 1 |
| OWP Pharmaceuticals, Inc. | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.27 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438287 | CMS |
| AbbVie Inc. | $28.91 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438291 | CMS |
| AbbVie Inc. | $18.94 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438295 | CMS |
| AbbVie Inc. | $26.68 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438299 | CMS |
| AbbVie Inc. | $24.83 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438303 | CMS |
| AbbVie Inc. | $23.93 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438307 | CMS |
| AbbVie Inc. | $22.79 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438311 | CMS |
| AbbVie Inc. | $20.56 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438315 | CMS |
| AbbVie Inc. | $22.79 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438319 | CMS |
| AbbVie Inc. | $30.61 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438323 | CMS |
| AbbVie Inc. | $28.29 | 10/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438327 | CMS |
| AbbVie Inc. | $17.25 | 11/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996438331 | CMS |
| Almatica Pharma LLC | $17.64 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993444257 | CMS |
| Corium, LLC | $34.14 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 976688513 | CMS |
| ITI, Inc. | $25.31 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040497901 | CMS |
| ITI, Inc. | $24.20 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040497911 | CMS |
| ITI, Inc. | $23.99 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040497917 | CMS |
| ITI, Inc. | $24.31 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040497926 | CMS |
| Janssen Pharmaceuticals, Inc | $17.39 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988648383 | CMS |
| Janssen Pharmaceuticals, Inc | $18.18 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988648385 | CMS |
| Lundbeck LLC | $15.11 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032196595 | CMS |
| Lundbeck LLC | $15.68 | 06/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032196601 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.57 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014276129 | CMS |
| OWP Pharmaceuticals, Inc. | $14.47 | 07/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1043256801 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.22 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055368863 | CMS |
| Teva Pharmaceuticals USA, Inc. | $30.19 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056969943 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.